Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis

Author(s):
Mease, P.; Hall, S.; FitzGerald, O.; Heijde, D. van der; Merola, J.F.; Avila-Zapata, F.; Cieslak, D.; Graham, D.; Wang, C.; Menon, S.; Hendrikx, T.; Kanik, K.S.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-10-19
Language
English
Is part of
New England Journal of Medicine (2017), Vol. 377, no. 16, p. 1537-1550
hdl
1887/116206
doi
10.1056/NEJMoa1615975